Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

794 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial.
Hurvitz SA, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Egorov A, Liu Y, Cathcart J, Bako E, Tecson K, Verma S, Cortés J. Hurvitz SA, et al. Among authors: egorov a. ESMO Open. 2024 May;9(5):102924. doi: 10.1016/j.esmoop.2024.102924. Epub 2024 Apr 24. ESMO Open. 2024. PMID: 38796287 Free article. Clinical Trial.
Drinking water sources, quality, and associated health outcomes in Appalachian Virginia: A risk characterization study in two counties.
Cohen A, Rasheduzzaman M, O'Connell B, Brown T, Taniuchi M, Krometis LA, Hubbard A, Scheuerman P, Edwards M, Darling A, Pennala B, Price S, Lytton B, Wettstone E, Pholwat S, Ward H, Hallinger DR, Simmons SO, Griffin SM, Kobylanski J, Egorov AI, Wade TJ. Cohen A, et al. Among authors: egorov ai. Int J Hyg Environ Health. 2024 May 20;260:114390. doi: 10.1016/j.ijheh.2024.114390. Online ahead of print. Int J Hyg Environ Health. 2024. PMID: 38772087
Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity.
Spector D, Bubley A, Zharova A, Bykusov V, Skvortsov D, Ipatova D, Erofeev A, Gorelkin P, Vaneev A, Mazur D, Nikitina V, Melnikov M, Pergushov V, Bunin D, Kuzmin V, Kostyukov A, Egorov A, Beloglazkina E, Akasov R, Krasnovskaya O. Spector D, et al. Among authors: egorov a. ACS Appl Bio Mater. 2024 May 20;7(5):3431-3440. doi: 10.1021/acsabm.4c00345. Epub 2024 May 2. ACS Appl Bio Mater. 2024. PMID: 38697834
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T, Cottone F, Dunton K, André F, Krop I, Park YH, De Laurentiis M, Miyoshi Y, Armstrong A, Borrego MR, Yerushalmi R, Duhoux FP, Takano T, Lu W, Egorov A, Kim SB. Fehm T, et al. Among authors: egorov a. Lancet Oncol. 2024 May;25(5):614-625. doi: 10.1016/S1470-2045(24)00128-1. Lancet Oncol. 2024. PMID: 38697155 Free article. Clinical Trial.
Structure-functional characterization of Lactococcus AbiA phage defense system.
Gapińska M, Zajko W, Skowronek K, Figiel M, Krawczyk PS, Egorov AA, Dziembowski A, Johansson MJO, Nowotny M. Gapińska M, et al. Among authors: egorov aa. Nucleic Acids Res. 2024 May 8;52(8):4723-4738. doi: 10.1093/nar/gkae230. Nucleic Acids Res. 2024. PMID: 38587192 Free PMC article.
794 results